SCHEMBL19970516

SCHEMBL19970516

CC(n1ncn(-c2ccc(OCC(F)(F)C(F)F)cc2)c1=O)C(O)(Cn1cncn1)c1ccc(F)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 16/20 0.51
CYP2C9 P11712 14/20 0.51
CYP2C19 P33261 13/20 0.51
CYP1A2 P05177 7/20 0.50
CYP2D6 P10635 7/20 0.50
KCNH2 Q12809 3/20 0.50
LMNA P02545 2/20 0.49
CYP2B6 P20813 1/20 0.49
CYP3A5 P20815 1/20 0.49
CYP3A7 P24462 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP3A43 Q9HB55 1/20 0.49
CYP46A1 Q9Y6A2 1/20 0.49
CYP19A1 P11511 2/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
HSP90AA1 P07900 1/20 0.44
ADRA1A P35348 1/20 0.44
CYP51A1 Q16850 1/20 0.44
ABCB11 O95342 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1456168 1.00 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL19970517 1.00 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7678338 0.97 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7681431 0.96 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8718973 0.96 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8053266 0.93 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8721160 0.92 CYP3A4 (0.52) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8721371 0.91 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL5928063 0.91 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8669563 0.91 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923101-B Cyclic compound 武田药品工业株式会社 2021-03-09 CN disclosed
CN-108368127-B Compounds and their use as EP4 receptor antagonists 武田药品工业株式会社 2020-12-11 CN disclosed
EP-3296296-A1 CYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2018-03-21 EP disclosed